PMID: 9546952Jan 1, 1997Paper

Role of endothelial cells in allograft rejection

Vascular Medicine
M L Rose

Abstract

The immunological properties of endothelial cells suggest they perform a pivotal role in acute and chronic rejection following solid organ transplantation. Their constitutive expression of MHC class II molecules (which initiate allograft rejection by activating CD4 T cells) and accessory molecules allows them to present foreign antigen by both the direct and indirect route to the recipient's immune system. The costimulatory molecules used by endothelial cells appear to differ from those used by traditional antigen-presenting cells such as B cells and dendritic cells. Release of non-HLA antigens from damaged endothelial cells results in a chronic antibody response--possibly contributing to graft vasculopathy and chronic rejection. Further understanding of the factors that regulate MHC class II and accessory molecule expression on endothelial cells could lead to novel strategies of therapeutic intervention.

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·L A TurkaD Gordon
Aug 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·N K Damle, A Aruffo
Sep 1, 1991·The Journal of Experimental Medicine·P S LinsleyJ A Ledbetter
May 1, 1991·Immunology Today·R E Morris
Mar 1, 1991·Transplantation·N Suciu-FocaD W King
Jun 15, 1990·Science·R H Schwartz
Oct 1, 1990·Transplantation·J S Pober, R S Cotran
Aug 1, 1989·The American Journal of Cardiology·K McDonaldM T Olivari
Sep 1, 1985·Transplantation·D Steinmuller
Nov 27, 1995·Transplantation·F XiaoL McChesney
Jul 1, 1994·Immunology Today·C H JuneC B Thompson
Sep 7, 1995·The New England Journal of Medicine·J A KobashigawaG A Cogert
Dec 1, 1994·British Heart Journal·A MatsumoriS Sasayama
Jan 28, 1994·Cell·C A Janeway, K Bottomly
Jan 1, 1994·Immunology Today·D A Shoskes, K J Wood
Feb 15, 1996·Transplantation·J S PoberC O Savage
Feb 15, 1996·Transplantation·K KawaiP S Ohashi
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·C ShiE Haber

❮ Previous
Next ❯

Citations

Sep 1, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Brian W WongBruce M McManus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2022 Meta ULC. All rights reserved